Nasdaq
·
Healthcare
·
Pharmaceuticals
·
Last Close
$138.36
▲ +0.16%
Key Metrics
P/E Ratio
17.80
FWD: 23.30
Market Cap
$171.56B
Large Cap
Div Yield
2.37%
Quarterly dividend
EPS Growth
-105.44%
YoY
RSI (14)
65.59
Momentum
Beta
0.35
vs Market
52W High
$157.26
12.02% below
52W Low
$108.52
27.50% above
Volume
1.50M
Avg 2.74M
P/B
6.71
Price-to-book
ROE
48.87%
Return on equity
Free Float
99.87%
Public shares
Historical Returns
5D
+3.87%
1M
+6.40%
3M
+4.77%
6M
-10.72%
YTD
+12.73%
1Y
+16.25%
3Y
+73.73%
5Y
+94.44%
Financials & Valuation
TTM · Annual
| Total Revenue | $29.44B |
| Net Income | $8.51B |
| Revenue Growth (YoY) | +10.18% |
| Gross Margin | 78.84% |
| Operating Margin | 39.99% |
| Net Profit Margin | 28.90% |
| ROE | 48.87% |
| ROA · ROIC | 16.60% · 20.10% |
| P/E Ratio | 17.80 |
| Forward P/E (FY1) | 23.30 |
| PEG Ratio | 0.01 |
| P/S | 5.23 |
| P/B | 6.71 |
| P/FCF | 16.29 |
| EPS Growth | -105.44% |
| Outstanding Shares | 1.24B |
Technical Indicators
| 50-Day SMA | $130.18 |
| 200-Day SMA | $132.45 |
| RSI (14) | 65.59 |
| Beta | 0.35 |
| 52-Week High | $157.26 |
| 52-Week Low | $108.52 |
| Volume Today | 1.50M |
| Avg Daily Volume (30D) | 2.74M |
| Relative Volume | 0.55x |
| Volatility (10D) | 24.31 |
| Volatility (30D) | 29.79 |
| Free Float | 99.87% |
